File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL
Supplementary

Article: Auto-antibody to Koc in patients with cancers

TitleAuto-antibody to Koc in patients with cancers
Authors
Issue Date2002
PublisherJilin Sheng Yixue Qikanshe. The Journal's web site is located at http://www.immune99.com/
Citation
Chinese Journal of Immunology (中國免疫學雜誌 Zhongguo Mianyixue Zazhi), 2002, v. 18 n. 1, p. 30-32 How to Cite?
AbstractBased on screening conditions on Koc (KH domain containing protein overexpressed in cancer) expression and purification, recombinant Koc was used as coating antigen for establishment of ELISA to detect anti-Koc of classes of IgM, IgG and IgA. The positive rates of anti-Koc were related to types of cancers, showing higher rates in hepatocellular cancer, rectum cancer and lung cancer, middle rates in stomach cancer, and lower rates in esophagus cancer. The last one was not significant, compared with normal control. When positive samples were defined as being positive for anti-Koc in at least one of three classes of Ig, the positive rates of hepatocellular cancer, rectum cancer, lung cancer, stomach cancer, esophagus cancer were 56.7%, 52.8%, 50.0%, 25.5% and 15.8%, respectively. Their positive rates were significantly higher than that of IgM, IgG or IgA anti-Koc in these cancers.
Persistent Identifierhttp://hdl.handle.net/10722/221646
ISSN

 

DC FieldValueLanguage
dc.contributor.authorWang, S-
dc.contributor.authorLiu, L-
dc.contributor.authorWang, L-
dc.contributor.authorLian, Q-
dc.contributor.authorLi, Q-
dc.contributor.authorPeng, X-
dc.date.accessioned2015-11-30T07:59:02Z-
dc.date.available2015-11-30T07:59:02Z-
dc.date.issued2002-
dc.identifier.citationChinese Journal of Immunology (中國免疫學雜誌 Zhongguo Mianyixue Zazhi), 2002, v. 18 n. 1, p. 30-32-
dc.identifier.issn1000-484X-
dc.identifier.urihttp://hdl.handle.net/10722/221646-
dc.description.abstractBased on screening conditions on Koc (KH domain containing protein overexpressed in cancer) expression and purification, recombinant Koc was used as coating antigen for establishment of ELISA to detect anti-Koc of classes of IgM, IgG and IgA. The positive rates of anti-Koc were related to types of cancers, showing higher rates in hepatocellular cancer, rectum cancer and lung cancer, middle rates in stomach cancer, and lower rates in esophagus cancer. The last one was not significant, compared with normal control. When positive samples were defined as being positive for anti-Koc in at least one of three classes of Ig, the positive rates of hepatocellular cancer, rectum cancer, lung cancer, stomach cancer, esophagus cancer were 56.7%, 52.8%, 50.0%, 25.5% and 15.8%, respectively. Their positive rates were significantly higher than that of IgM, IgG or IgA anti-Koc in these cancers.-
dc.languageeng-
dc.publisherJilin Sheng Yixue Qikanshe. The Journal's web site is located at http://www.immune99.com/-
dc.relation.ispartofChinese Journal of Immunology (中國免疫學雜誌 Zhongguo Mianyixue Zazhi)-
dc.titleAuto-antibody to Koc in patients with cancers-
dc.typeArticle-
dc.identifier.emailLian, Q: qzlian@hkucc.hku.hk-
dc.identifier.authorityLian, Q=rp00267-
dc.identifier.volume18-
dc.identifier.issue1-
dc.identifier.spage30-
dc.identifier.epage32-
dc.publisher.placeChina-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats